Research
McGill discovery sheds new light on autism, intellectual disabilities
Breakthrough that stands to rewrite the textbooks on brain function could lead to treatments A new study by McGill University researchers yields insights...
April 11, 2025
Julia Burnier: Engaging patients in research
Oncology researcher is building partnerships with cancer agencies to empower patients and transform research As Program Director of the Global Oncology Program in...
April 11, 2025
Genetic sequencing project receives more than $8 million in funding
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians A project led by Ziv Gan-Or, MD, PhD,...
April 3, 2025
Anti-swelling drug reduces immune response in brain cancer patients weeks after last dose
Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy Swelling caused by brain cancer is a problem that can lead to...
April 2, 2025
GLP-1 diabetes drugs not linked to heightened suicidality risk
Despite previous concerns, findings provide reassurance about the psychiatric safety of these drugs, say researchers from the Lady Davis Institute for Medical Research...
April 2, 2025
Latest Alzheimer’s drug shown less effective in women
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi,...
April 2, 2025
COVID-19 boosters help avoid breakthrough infections in immunocompromised people, McGill-led study finds
Researchers focused on those with rheumatoid arthritis, lupus, inflammatory bowel disease, multiple sclerosis and other immune-mediated inflammatory diseases New research findings provide solid...
April 2, 2025
AI analysis challenges autism diagnosis criteria
Researchers suggest behavioural traits are more telling than social communication and interaction factors, so diagnostic focus should be sharpened An analysis of digital...
April 2, 2025
Génome Québec and Cystic Fibrosis Canada invest $1.2 million in research tackling rare, orphan CFTR mutations
Génome Québec and Cystic Fibrosis Canada today announced a $1.2 million investment in two new research projects focused on rare genetic mutations that...
April 2, 2025
PAP therapy may improve cognitive function in Parkinson’s disease
Research highlights potential cognitive and symptom improvements in Parkinson’s patients through treatment of obstructive sleep apnea with Positive Airway Pressure (PAP) therapy A...
March 28, 2025
Project to create AI model for ALS receives Génome Québec funding
$400,000 will fuel public-private collaboration to discover new disease biomarkers A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early...
March 28, 2025
Addressing health disparities through genomics
Researcher from The Institute co-leads $8.3 million genomics sequencing project to advance healthcare for Black communities Loydie Jerome-Majewska, PhD, a senior scientist at the...
March 28, 2025